AMG7905 is a transient receptor potential vanilloid type 1 (TRPV1) antagonist that induces hypothermia by enhancing proton-mediated activation of the TRPV1 channel, thereby driving reflexive inhibition of thermogenesis and cutaneous vasoconstriction in the tail, while potently blocking capsaicin-induced channel activation.